Treatment of Coronary In-Stent Restenosis
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 199 participants.
Also called NCT01735825
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 199 participants
- Sponsor
- Registry
-
NCT01735825
-
- Other papers using this trial's data
- Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study
- Long-term outcomes after treatment of bare-metal stent restenosis with paclitaxel-coated balloon catheters or everolimus-eluting stents: 3-year follow-up of the TIS clinical study
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Czechia
- Registry status
- Completed
Technical summary
Registry record NCT01735825. Randomized; double masking; primary purpose treatment. Start 2012-01 (actual); primary completion 2015-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Treatment of Coronary In-Stent Restenosis
- Acronym
- TIS
- Condition
- Restenosis
- Intervention (Device)
- paclitaxel-coated balloon catheter with Iopromide coating
- Intervention (Device)
- drug eluting stent with everolimus
- Intervention (Device)
- seal-wing paclitaxel-eluting balloon catheter
- Lead sponsor
- University Hospital Ostrava
Record details
- Record id
cardio:ct-nct01735825- Content hash
9b0cad623a327999f4ae75f4166478ccf6a84c4edbf03f582504fe29fa2fd4e1